MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ejphar.2025.178431

Медицинская библиотека · European journal of pharmacology · 2025

Methylnissolin mitigates microglia-mediated neuroinflammation and ischemic brain injury through PI3K/AKT and MAPK pathways.

Wu Jie, Jiang Maoyuan, Yin Yanping, Zhang Zhi, Sun Liang, Yang Miao, Yang Haiyan, Bao Xinyu, Xia Shengnan, Xu Yun

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Neuroinflammation driven by activated microglia is a major contributor to secondary brain damage following ischemic stroke. Targeting microglial activation has thus emerged as an important therapeutic strategy. Methylnissolin (ML), a pterocarpan-type isoflavonoid with documented anti-inflammatory activity and predicted ability to cross the blood-brain barrier, represents a potential modulator of microglial responses.

METHODS

Primary microglia subjected to oxygen-glucose deprivation/reoxygenation (OGD/R) and mice subjected to transient middle cerebral artery occlusion (tMCAO) were treated with ML. Microglial inflammatory responses were measured by RT-qPCR, Western blotting, Enzyme-linked immunosorbent assay, and immunofluorescence. Brain pathological alterations were assessed by 2,3,5-triphenyltetrazolium chloride (TTC) staining, Evans blue extravasation, and brain water content measurement. Behavioral changes was evaluated using grip strength, rotarod, modified neurological severity score (mNSS), and foot-fault tests. RNA sequencing (RNA-seq) and targeted protein-level analyses were performed to investigate signaling pathways.

RESULTS

ML markedly reduced the OGD/R-induced expression of pro-inflammatory mediators (IL-1β, IL-6, TNF-α, iNOS, COX-2) and suppressed activation of the PI3K/AKT and MAPK pathways in microglia. In tMCAO mice, ML treatment lessened infarct volume, brain edema, and blood-brain barrier leakage, preserved neuronal morphology, and improved neurological performance. RNA sequencing and biochemical analyses in primary microglia showed modulation of the PI3K/AKT and MAPK signaling cascades by ML.

CONCLUSION

ML mitigates microglia-mediated neuroinflammation and protects against ischemic brain injury by downregulating the PI3K/AKT and MAPK pathways, suggesting that ML may be a promising therapeutic candidate for ischemic stroke.

Для цитирования: Wu Jie, Jiang Maoyuan, Yin Yanping, Zhang Zhi, Sun Liang, Yang Miao, Yang Haiyan, Bao Xinyu, Xia Shengnan, Xu Yun. Methylnissolin mitigates microglia-mediated neuroinflammation and ischemic brain injury through PI3K/AKT and MAPK pathways.. European journal of pharmacology. 2025. DOI: 10.1016/j.ejphar.2025.178431.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.